Recognition of intercenter differences may help develop best practice

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 5, 2008, Pages 347-354

  Norda, Rut ^a   Axelsson, Claes Göran ^b   Axdorph, Ulla ^c   Berlin, Gösta ^d   Wikström, Björn ^a   Stegmayr, Bernd ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse effect; Albumin; Apheresis; Fresh frozen plasma; Plasma exchange; Registry

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRESH FROZEN PLASMA; IMMUNOGLOBULIN G;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; APHERESIS; ARTICLE; BACKACHE; BLOOD CLOTTING; CLINICAL PRACTICE; CONTROLLED STUDY; DIZZINESS; DYSPNEA; FLUSHING; GUILLAIN BARRE SYNDROME; HEALTH CENTER; HEART ARRHYTHMIA; HEMATOMA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERVISCOSITY SYNDROME; HYPOTENSION; INFECTION; MACROGLOBULINEMIA; MAJOR CLINICAL STUDY; MORBIDITY; NAUSEA; PARESTHESIA; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEIZURE; SHIVERING; SIDE EFFECT; STOMACH PAIN; THORAX PAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNIVERSITY HOSPITAL; URTICARIA; VASOSPASM;

BLOOD COMPONENT REMOVAL; FEMALE; HEALTH CARE SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; LINEAR MODELS; MALE; NEEDS ASSESSMENT; OUTCOME ASSESSMENT (HEALTH CARE); PLASMA EXCHANGE; PLASMAPHERESIS; PREVALENCE; PROBABILITY; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SWEDEN;

EID: 53749103715     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00608.x     Document Type: Article

References (23)

1. Korach JM, Petitpas D, Paris D et al. Plasma exchange in France: epidemiology. Transf Apher Sci 2001 29 : 153 7. 2003.
2. Taraldsrud E, Kvalheim G, Jorstad S, Stavem K, Aandahl GS. A survey of therapeutic hemapheresis in Norway year 2000. Transfus Apher Sci 2003 28 : 135 41.
3. Rock G, Clark B, Sutton D. The Canadian apheresis registry. Transfus Apher Sci 2003 29 : 167 77.
4. Malchesky PS, Koo AP, Roberson GA, Hadsell AT, Rybicki LA. Apheresis technologies and clinical applications: the 2002 international apheresis registry. Ther Apher Dial 2004 8 : 124 43.
5. Passalacqua S, Staffolani E, Busnach G et al. The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology. J Clin Apher 2005 20 : 101 6.
6. Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion 1989 29 : 124 7.
7. McLeod BC, Sniecinski I, Ciavarella D et al. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999 39 : 282 8.
8. Korach JM, Guillevin L, Petitpas D, Berger P, Chillet P. Apheresis registry in France: indications, techniques, and complications. French Registry Study Group. Ther Apher 2000 4 : 207 10.
9. Norda R, Stegmayr BG. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 2003 29 : 159 66.
10. Korach JM, Petitpas D, Poiron L, Vincent N, Berger PH, Chillet P. 14 years of therapeutic plasma exchange in France. Transfus Apher Sci 2001 25 : 73 7.
11. Kiprov DD, Golden P, Rohe R, Smith S, Hofmann J, Hunnicutt J. Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures. J Clin Apher 2001 16 : 130 3.
12. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 1994 34 : 891 4.
13. Huestis DW. Mortality in therapeutic hAEmapheresis. Lancet 1983 1 : 1043.
14. Weinstein R. Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange. J Clin Apher 2001 16 : 210 11.
15. Weinstein R. Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid. J Clin Apher 1996 11 : 204 10.
16. Strauss RG. Mechanisms of adverse effects during hemapheresis. J Clin Apher 1996 11 : 160 4.
17. Brecher ME, Owen HG, Bandarenko N. Alternatives to albumin: starch replacement for plasma exchange. J Clin Apher 1997 12 : 146 53.
18. Leblond PF, Rock G, Herbert CA. The use of plasma as a replacement fluid in plasma exchange. Canadian Apheresis Group. Transfusion 1998 38 : 834 8.
19. Rock G, Sutton DM, Freedman J, Nair RC. Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. J Clin Apher 1997 12 : 165 9.
20. LeConte P, Nicolas F, Adjou C, N'Guyen J, Billard E, Moreau P. Replacement fluids in plasmapheresis: cross-over comparative study. Intensive Care Med 1997 23 : 342 4.
21. Korach JM, Berger P, Giraud C, Le Perff-Desman C, Chillet P. Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group. Intensive Care Med 1998 24 : 452 8.
22. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005 152 : 3 12.
23. Auwerda JJ, Leebeek FW, Wilson JH, van Diggelen OP, Lam KH, Sonneveld P. Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 2006 46 : 1705 11.